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Background: Studies investigating the associations between transcription factor 4 (TCF4) genetic polymorphisms
and Fuchs’ endothelial dystrophy (FED) have reported controversial results. Therefore, this meta-analysis aims to
clarify the effects of TCF4 polymorphisms on FED risk.
Methods: A meta-analysis was conducted to assess the association between four single nucleotide polymorphisms
(SNPs) inTCF4 and the risk of FED. Relevant studies were selected through an extensive search of PubMed, EMBASE,
and the Web of Science databases. Pooled odds ratio (OR) and 95 % confidence interval (CI) were calculated using
the random-effects model.
Results: Thirteen studies were included in this systematic review and meta-analysis. The pooled results showed that
there was a strong positive association between the TCF4 rs613872 polymorphism and FED risk in all the genetic
models tested (G allele vs. T allele: OR = 4.19, 95 % CI = 3.53–4.97; GG vs. GT/TT: OR = 4.27, 95 % CI = 2.54–7.19;
GG/GT vs. TT: OR = 6.29, 95 % CI = 4.23–8.93; GG VS. TT: OR = 10.64, 95 % CI = 5.28–21.41; GT VS. TT: OR = 6.08, 95 %
CI = 4.28–8.64). Statistic evidence was also detected for a significant association between three other SNPs and the
risk of FED.
Conclusions: This meta-analysis suggested a genetic association between four TCF4 polymorphisms (rs613872,
rs2286812, rs17595731, and rs9954153) and the risk of FED.Background
Fuchs’ endothelial dystrophy (FED) is a familial, slowly
progressive, and irreversible disorder affecting the cor-
neal endothelial cell monolayer [1]. It has been reported
that, in the United States, FED affects about 4 % of the
population over the age of forty [2], making it the most
common genetic disorder of the corneal endothelium.
The most important signs of FED are the thickening of
Descemet’s membrane and microscopic collagenous ex-
crescences known asguttae [3]. Disease progression re-
sults in reduced vision as a result of the edema in the
cornea, which is caused by loss of the fluid-pumping
function of the endothelium [4].
Although the precise reason for FED remains unclear,
recent studies have reported significant insights into the
genetic basis of the disorder. To date, several gene* Correspondence: drpengxy@163.com
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creativecommons.org/publicdomain/zero/1.0/mutations, such as collagen type 8 alpha-2 (COL8A2),
the sodium borate cotransporter gene (SLC4A11), tran-
scription factor 8 (TCF8), and transcription factor 4
(TCF4), have been implicated in the pathogenesis of
FED [5–8]. Of these gene mutations, the TCF4 variations
have been considered to be associated with a number of
diseases, such as FED, schizophrenia, and primary scler-
osing cholangitis [8–10]. The TCF4 gene is located on
chromosome 18q [11]. It encodes a transcription factor
protein, E2-2, which is a member of the E protein family
that is expressed in the cornea during development and
which is involved in regulating cellular growth and dif-
ferentiation [12].
Recently, TCF4 polymorphisms have attracted a lot of
attention. A previous genome-wide association study
(GWAS) showed a significant relationship between FED
and four genotyped single nucleotide polymorphisms
(SNPs) (rs17595731, rs613872, rs9954153, and rs2286812)
of the TCF4 gene [8]. Since then, several case–control
studies have also been conducted and they have also
shown that the TCF4 polymorphisms are associated withdistributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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sive. For example, Nanda et al. [17] reported that the
TCF4 rs613872 polymorphism was not associated with
FED, but Kuot et al. [11] found that the TCF4 rs613872
polymorphism was a risk factor for FED. Other SNPs of
TCF4 (rs2286812, rs17595731, and rs9954153) were also
analyzed in some FED genetic association studies.
Meta-analysis is a powerful statistical technique that is
often used in combination with different studies; there-
fore, it draws a more comprehensive conclusion. With this
in mind, we conducted a meta-analysis to summarize all
the relevant evidence for an association between the risk
of FED and genetic polymorphisms of TCF4, which in-




Literature searches were performed in PubMed (http://
www.ncbi.nlm.nih.gov/pubmed/), ISI Web of Science
(www.webofknowledge.com), and EMBASE (http://
www.embase.com) databases. Key search terms in-
cluded (“Fuchs’ endothelial dystrophy,” or “Fuchs’
endothelial corneal dystrophy,”) and (“transcription fac-
tor 4,” or “TCF4,”or “immunoglobulin transcription fac-
tor 2,” or “E2-2,” or “SL3-3 enhancer factor 2,” or “SEF2,”
or “rs613872,” “rs17595731” or “rs2286812” OR “rs9954
153”) and (“polymorphism,” or “variation,” or “mutation,”
or “variant,” or “genotype,” or “allele”). References cited in
each eligible literature were manual checked until no fur-
ther studies were found. If the overlapping patient popula-
tion was included in several studies, the latest study was
included. The final literature search was updated on April
05, 2015, with no restrictions as to publication year, lan-
guage, or methodological filter.
Inclusion and exclusion criteria
Studies included in this meta-analysis were required to
meet the following inclusion criteria: (a) designed as
nested case–control, case–control, or GWAS; (b) evalu-
ated TCF4 polymorphism and FED; (c) odds ratio (OR)
and the corresponding 95 % confidence interval (CI)
were provided; and (d) sufficient genotypic or allelic in-
formation was provided to estimate. Exclusion criteria
were: (a) case-only studies, familial studies, or duplicate
data; (b) abstracts, comments, letters, reviews, or editor-
ial articles; (c) insufficient genotyping data.
Data extraction and quality assessment
Two observers (L.D. and S.H.Y.) independently extracted
the following information from included studies, using a
standardized data extraction form: first author, year of
publication, country of origin, population ethnicity, source
of controls, numbers of genotyped cases and controls, andHardy-Weinberg equilibrium (HWE) for the control
group. If a study provided several risk estimates, the best
adjusted estimate was extracted. Any disagreement was
resolved by discussion or adjudicated with the involve-
ment of a third reviewer (P.X.Y.). The quality of each
study was assessed using the Newcastle-Ottawa Scale
(NOS) [18]. The NOS uses a “star” rating system to judge
quality, based on three aspects of the study: selection,
comparability, and exposure; scores range from 0 stars
(worst) to 9 stars (best). Studies with a score of ≥ 7 were
considered of high quality [19]. Any discrepancies were
addressed by means of discussion and consensus.
Statistical analyses
ORs and 95 % CIs were used to assess the strength of
the associations between TCF4 polymorphisms and FED.
Adjusted ORs and 95%CIs were used if they were re-
ported; otherwise, the pooled ORs and 95 % CIs without
adjustments were calculated for the following genotypic
models for rs613872 SNP: allele (G vs. T); homozygote
(GG vs. TT), heterozygote (GT vs. TT), dominant (GG/
GT vs. TT), and recessive (GG vs. GT/TT). Due of the
insufficient data for the other three TCF4 SNPs, the
pooled ORs and the 95 % CIs were calculated using an
additive model. Data were combined using a random ef-
fects model to achieve more conservative estimates. Stat-
istical heterogeneity between the studies was evaluated
using Cochran’s Q test and the I2 statistic. For the Q
statistic, p < 0.05 was considered to indicate statistically
significant heterogeneity [20]. I2 was also used to assess
the heterogeneity in the meta-analysis, and heterogeneity
was said to exist when I2 > 50 % [21]. To determine the
reliability of the outcomes of the meta-analysis, a sensi-
tivity analysis was performed by the exclusion of an indi-
vidual study each time. Furthermore, we repeated the
sensitivity analyses to delete the findings from studies
that deviated from the HWE principle [22] and to
calculate the pooled ORs for the remainder of the stud-
ies [8, 13–17, 23–25]. Finally, to detect publication
biases, Begg’s and Egger’s measures were calculated and
assessed using Begg’s funnel plots [26, 27]. A p value less
than 0.05 was considered statistically significant in the
test for overall effect. The analysis was conducted using
the Stata software package (Version 12.0; Stata Corp.,
College Station, TX, USA).
Results
Literature search and characteristics
The initial search yielded 868 potentially relevant stud-
ies. After the removal of duplicates through electronic
databases, 634 studies remained. Based on titles and ab-
stracts, 616 articles were excluded because of their
apparent irrelevance. In total, 18 full-text articles were
further assessed for eligibility. Of these, six articles were
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review (n = 1) [28]; the articles lacked controls (n = 3)
[29–31]; and the articles did not focus on the relative
polymorphism (n = 2) [32, 33]. Finally, 12 articles met
the inclusion criteria and were included in this meta-
analysis [8, 13–17, 22–25, 34, 35]. One trial [8], reported
the allele and the genotype of the discovery group and
the replication group, respectively. We assumed that the
discovery group and the replication group were the sub-
jects in two separate studies. Overall, 13 studies were
included in this meta-analysis. Of these, 11 studies
reported the association between the TCF4 rs613872
polymorphism and FED. Three studies reported the as-
sociation between the TCF4 rs9954153 polymorphism
and FED. Three studies reported the association between
the TCF4 rs17595731 polymorphism and FED. Five
studies reported the association between the TCF4
rs2286812 polymorphism and FED. The study selection
process is detailed in Fig. 1. The main characteristics of
the included studies are presented in Table 1. Among
these studies, nine originated from the United States,Fig. 1 Flow diagram outlining the selection process for inclusion of studiesone from Australia, one from India, one from China,
and one from Singapore. Thirteen studies included 2468
FED cases and 2902 controls. The NOS results showed
that the average score was 7.9 (range: 7 to 9), indicating
that the methodological quality was generally good.
Meta-analysis of TCF4 rs613872polymorphism and FED
Table 2 presents the main results of the pooled ORs and
the heterogeneity test of the meta-analysis. For rs613872,
the pooled ORs showed that there was a strong positive
association between the TCF4 rs613872 polymorphism
and FED risk in all the genetic models tested (G allele vs.
T allele: OR = 4.19, 95 % CI = 3.53–4.97 (Fig. 2); GG vs.
GT/TT: OR = 4.27, 95 % CI = 2.54–7.19; GG/GT vs. TT:
OR = 6.29, 95 % CI = 4.23–8.93; GG vs.TT: OR = 10.64,
95 % CI = 5.28–21.41; GT vs. TT: OR = 6.08, 95 % CI =
4.28–8.64). Among the studies, significant heterogeneity
was detected in the dominant model (GG/GT vs. TT) and
the heterozygote model (GT vs. TT) (Table 2). For
rs2286812, five studies were included for calculation and
the pooled ORs and 95%CI was 1.77(1.19–2.63) in thein the systematic review and meta-analysis
Table 1 Characteristics of included studies








Baratz (2010)a [8] USA Caucasian GWAS Taqman assay 130/260 HB rs613872,rs17595731, yes
rs9954153,rs2286812
Baratz (2010)b [8] USA Caucasian GWAS Taqman assay 150/150 HB rs613872,rs17595731, yes
rs9954153,rs2286812
Li (2011) [23] USA Caucasian Case–control Taqman assay 450/340 HB rs613872 yes
Riazuddin (2011) [24] USA Caucasian Case–control Taqman assay 170/180 HB rs613872 yes
Thalamuthu (2011) [34] Singapore Asian Case–control MassArray 57/121 HB rs2286812 yes
Igo (2012) [22] USA Caucasian Case–control Taqman assay 531/204 HB rs613872 no
Kuot (2012) [16] Australia Caucasian Case–control MassArray 103/275 HB rs613872,rs9954153, yes
rs2286812,rs17595731
Stamler (2013) [15] USA Caucasian Case–control Taqman assay 82/163 HB rs613872 yes
Nanda (2014) [17] India Asian Case–control PCR-sequencing 44/108 HB rs613872 yes
Wang (2014) [35] China Asian Case–control Taqman assay 34/491 HB rs2286812 yes
Li (2014) [19] USA Caucasian Case–control Taqman assay 529/494 HB rs613872 yes
Mootha (2014) [13] USA Caucasian Case–control Taqman assay 120/100 HB rs613872 yes
Wieben (2014) [25] USA Caucasian Case–control PCR-sequencing 68/16 HB rs613872 yes
HW-E Hardy Weinberg equilibrium; PCR polymerase chain reaction; HB hospital-based
aThe data extracted from discovery group
bThe data extracted from replication group
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with the risk of FED. Significant associations were also ob-
served for rs17595731 and rs9954153 (Table 2).
Sensitivity analysis and publication bias
To evaluate the influence of an individual data set on
the pooled results, one study was deleted at a time. The







G vs. T 10 4.19(3.53–4.97) <0.001
GG vs. GT/TT 6 4.27(2.54–7.19) <0.001
GG/GT vs. TT 7 6.29(4.23–8.93) <0.001
GG VS. TT 6 10.64(5.28–21.41) <0.001
GT VS. TT 6 6.08 (4.28–8.64) <0.001
rs2286812
T vs C 5 1.77(1.19–2.63) 0.005
rs17595731
C vs G 3 4.70(3.06–7.21) <0.001
rs9954153
G vs T 3 2.43(1.97–3.01) <0.001
TCF4 transcription factor 4; FED Fuchs endothelial dystrophy; OR odds ratio; CI conf
aP Egger’s test = the P value for Egger’s test
bP Begg’s test = the P value for Begg’s teststudy was deleted, suggesting the high stability of the
meta-analysis results for TCF4 rs613872 (Table 3). This
analysis of the association between theTCF4 rs613872
polymorphism and FED risk also revealed that one study
by Nanda et al. [17] was the main origin of heterogeneity
(Table 3). The I2 significantly declined from 45.8 % to
0.0 % (Q = 7.69, p = 0.464) after removing the study by








16.60 45.8 % 0.055 0.411 0.474
6.20 19.3 % 0.288 0.295 0.260
16.23 63.0 % 0.013 0.586 0.707
9.43 47.0 % 0.093 0.378 0.452
12.72 60.7 % 0.026 0.938 0.707
12.10 66.9 % 0.017 0.207 0.180
1.27 0.0 % 0.530 0.775 1.000
0.20 0.0 % 0.906 0.793 1.000
idence Interval
Fig. 2 Forest plot for the association between TCF4 rs613872 polymorphism and FED risk (G allele vs. T allele). OR: odds ratio; CI: confidence
interval; TCF4: transcription factor 4; FED: Fuchs endothelial dystrophy
Table 3 Sensitivity analysis of the meta-analysis results for TCF4
rs613872 polymorphism and FED risk (G allele vs. T allele)
Random effects model Test of homogeneity
Study Excluded OR 95%CI Q I2 (%) P-value
None 4.19 3.53–4.97 16.60 45.8 0.055
Baratz (2010)a [8] 4.23 3.52–5.09 16.22 50.7 0.039
Baratz (2010)b [8] 4.19 3.48–5.04 16.58 51.8 0.035
Li (2011) [23] 4.26 3.50–5.19 15.12 47.1 0.057
Riazuddin (2011) [24] 4.16 3.43–5.04 16.59 51.8 0.035
Igo (2012) [22] 4.11 3.41–4.96 16.20 50.6 0.040
Kuot (2012) [16] 4.19 3.46–5.09 16.53 51.6 0.035
Stamler (2013) [15] 4.21 3.48–5.08 16.46 51.4 0.036
Nanda (2014) [17] 4.38 3.89–4.94 7.69 0.0 0.464
Li (2014) [19] 4.01 3.37–4.78 12.57 51.4 0.042
Mootha (2014) [13] 4.05 3.42–4.80 13.78 41.9 0.088
TCF4 transcription factor 4; FED Fuchs’ endothelial dystrophy; OR odds ratio; CI
confidence Interval
aThe data extracted from discovery group
bThe data extracted from replication group
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the results from the remaining studies were similar to
the overall result, and a significant association was de-
tected in all the genetic models. We also performed
“leave-one-out” sensitivity analyses for the other three
SNPs and the results showed that no single study influ-
enced the pooled results (data not shown). Publication
bias was estimated using Begg’s funnel plot and Egger’s
test (Table 2). No significant publication bias was
observed in this meta-analysis. In addition, the funnel
plot for studies of the association between theTCF4
rs613872 polymorphism and FED risk under an additive
model (G allele vs. T allele) is presented in Fig. 3.
Discussion
Despite the fact that the GWAS publication noted that
genetic variations in TCF4 polymorphisms contribute to
the development of FED, this correlation also needs to
be verified by a case control study. Therefore, we per-
formed this meta-analysis to provide the highest level of
evidence for the association between TCF4 polymor-
phisms and the risk of FED. With a total of 5370 partici-
pants, this meta-analysis focused on the association
between TCF4 variants and the risk of FED, thirteen
studies addressing one or more SNPs in TCF4 (rs613872,
rs17595731, rs9954153, and rs2286812) were included.
The pooled results showed that a significant association
was detected between FED risk and the rs17595731, rs613
872, rs9954153, and rs2286812 SNPs. This s consistent
with the findings presented in the GWAS publication [8].For rs613872, in order to achieve robust and reliable re-
sults for the meta-analysis of the association between
rs613872 and FED risk, we performed a series of analyses.
These sensitivity analyses were performed by excluding
one individual study each time. This procedure did not
greatly change the pooled results; rather, it supported their
reliability. In addition, it should be noted that the genetic
distributions of the controls in one study deviated
from HWE, indicating the possibility of bias. Thus,
Fig. 3 Funnel plot for studies of the association of TCF4 rs613872 polymorphism and FED risk (G allele vs. T allele). OR: odds ratio; TCF4:
transcription factor 4; FED: Fuchs endothelial dystrophy
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that study. The results from the pooled ORs before
and after omitting the studies that deviated from the
studies that used the HWE principles were similar,
suggesting that the results were minimally affected by
this study. In addition, for the other SNPs, no indi-
vidual study influenced the pooled results Further-
more, no significant publication bias was observed in
the pooled results in all four of the SNPs, further
demonstrating the robustness of our meta-analysis.
Differences in ethnic groups may affect genetic predis-
position to human diseases [36, 37]. In the present
meta-analysis, we found that only one study from India
did not detect the association between the TCF4 rs613872
polymorphism and the risk of FED, which might be due to
the different ethnicity of the included study participants
[17]. Another study from Asian also showed no associ-
ation between rs2286812 and the risk of FED, which also
might be due to the different ethnicity of the study popu-
lation. However, only one study with a small sample size
should be considered. In the future, more epidemiologic
studies of people with Asian ethnicity using larger sample
sizes are needed to further confirm this difference.
To date, the pathomechanism underlying the associ-
ation between the TCF4 gene and FED risk is still un-
clear. Possible mechanisms for the association between
the TCF4 gene and FED risk have been proposed. First,
the protein produced by the TCF4 gene (E2-2) might
participate in endothelium growth, proliferation, and dif-
ferentiation [38]. Therefore, loss of function in this pro-
tein through gene mutations would reduce the numberof endothelial cells, as observed in FED patients [8]. In
addition, the E2-2 protein has been shown to up-
regulate the protein expression of zinc finger E-box
binding homeobox 1 (ZEB1), which has been found to
be the pathogenic protein of FED. Thus, this indirectly
showed that the TCF4 gene mutation associated with
FED results from changes in the expression of ZEB1 [8].
Taken together, these proofs supported the hypothesis
that the TCF4 gene might heighten the risk of FED.
An important aim of meta-analysis is to determine
the sources of heterogeneity. In this meta-analysis, sub-
stantial heterogeneity was observed in the dominant
model (I2 = 63.0 %; p = 0.013), and the heterozygote
model (I2 = 60.7 %; p = 0.026) for rs613872. We per-
formed the sensitivity analysis by exclusion of one indi-
vidual study each time and we found that the study by
Nanda et al. [17] might be the source of heterogeneity,
as heterogeneity was significantly decreased after ex-
cluding that study. For rs2286812, substantial hetero-
geneity was also observed in the additive model and the
sensitivity analysis also showed that Wang’s [35] study
is the source of the heterogeneity.
In performing a quantitative analysis of the relation-
ship between TCF4 polymorphisms and FED risk, this
meta-analysis was also limited. First, the number of ori-
ginal studies included in the meta-analysis was relatively
small; for rs17595731, rs9954153, and rs2286812, only
three to five studies were included. Second, substantial
heterogeneity was observed among the studies. However,
we determined that the source of this heterogeneity was
the single study from India for rs613872. When this
Li et al. BMC Ophthalmology  (2015) 15:61 Page 7 of 8study was excluded, the results of the remaining studies
did not change, and the heterogeneity was greatly re-
duced. Third, the genotyping methods differed among
these studies, which may have affected the results.
Fourth, it should be noted that the HWE test was not
performed in one of the studies, which may have in-
creased selection bias in the control. However, when that
study was excluded the summary OR was unchanged in
the remaining studies, which suggested the high stability
of the results of this meta-analysis.
Conclusions
In conclusion, this meta-analysis suggested a genetic as-
sociation between four TCF4 polymorphisms (rs613872,
rs2286812, rs17595731, and rs9954153) and the risk of
FED. Despite these encouraging findings, the inherent
limitations of the studies should be considered, and con-
clusions drawn from the pooled results should be inter-
preted with caution. In the future, more epidemiologic
studies of other ethnicities with a well-designed and
larger sample size are needed to further confirm our
findings.
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